CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 165 filers reported holding CHEMOCENTRYX INC in Q1 2020. The put-call ratio across all filers is 0.52 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,025,000 | +372.4% | 19,838 | +126.1% | 0.00% | – |
| Q2 2022 | $217,000 | -85.7% | 8,774 | -70.3% | 0.00% | -100.0% |
| Q1 2021 | $1,513,000 | -20.0% | 29,527 | -3.3% | 0.00% | -33.3% |
| Q4 2020 | $1,891,000 | -1.4% | 30,547 | -12.7% | 0.00% | 0.0% |
| Q3 2020 | $1,918,000 | -19.4% | 34,991 | -15.4% | 0.00% | -25.0% |
| Q2 2020 | $2,381,000 | +35.7% | 41,374 | -5.2% | 0.00% | +33.3% |
| Q1 2020 | $1,754,000 | +690.1% | 43,648 | +677.8% | 0.00% | – |
| Q4 2019 | $222,000 | +74.8% | 5,612 | -58.8% | 0.00% | – |
| Q2 2019 | $127,000 | -59.2% | 13,606 | -39.2% | 0.00% | – |
| Q1 2019 | $311,000 | +27.5% | 22,364 | 0.0% | 0.00% | – |
| Q4 2018 | $244,000 | -13.8% | 22,364 | 0.0% | 0.00% | – |
| Q3 2018 | $283,000 | -4.1% | 22,364 | 0.0% | 0.00% | – |
| Q2 2018 | $295,000 | – | 22,364 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 276,400 | $4,726,000 | 1.88% |
| TANG CAPITAL MANAGEMENT LLC | 500,000 | $8,550,000 | 1.78% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 94,300 | $7,131,000 | 1.72% |
| Integral Health Asset Management, LLC | 300,000 | $5,130,000 | 1.48% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 139,200 | $2,380,000 | 1.35% |
| MANGROVE PARTNERS IM, LLC | 686,300 | $11,736,000 | 1.05% |
| Ikarian Capital, LLC | 600,000 | $10,261,000 | 0.72% |
| Ikarian Capital, LLC | 600,000 | $10,260,000 | 0.72% |
| Sofinnova Investments, Inc. | 517,708 | $8,853,000 | 0.52% |
| Birchview Capital, LP | 25,000 | $428,000 | 0.29% |